ArticleInternational journal of preventive medicine2026
Cost-Utility Analysis of High-Intensity Statins; Atorvastatin 40 and 80 mg versus Rosuvastatin 20 mg from Egyptian Public Payer's Perspective: A Markov Model.
Ahmed Ibrahim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.